, Tracking Stock Market Picks
Enter Symbol:
Affymax, Inc. (AFFY) [hlAlert]

down 98.77 %

Affymax, Inc. (AFFY) upgraded to Buy with price target $10 by Auriga U.S.A

Posted on: Friday,  Mar 11, 2011  8:25 AM ET by Auriga U.S.A

Auriga U.S.A rated Buy Affymax, Inc. (OTCBB: AFFY) on 03/11/2011, when the stock price was $7.00. Since
then, Affymax, Inc. has lost 98.77% as of 08/27/2015's recent price of $0.09.
If you would have followed this Auriga U.S.A's recommendation on AFFY, you would have lost 98.77% of your investment in 1630 days.

Affymax, Inc. is a biopharmaceutical company developing peptide-based drugs to improve the treatment of serious and often life-threatening conditions. The Company's product candidate, Hematide, is designed to treat anemia associated with chronic renal failure. Hematide is a relatively small synthetic peptide-based erythropoiesis stimulating agent (ESA), which it is developing for the treatment of anemia patients with chronic renal failure. The Company is conducting Phase III clinical trials in patients suffering from chronic renal renal failure, on dialysis and not on dialysis (pre-dialysis). In August 2008, the Company and Takeda Pharmaceutical Company Limited (Takeda), agreed to suspend development of Hematide to treat chemotherapy induced anemia.

Auriga is committed to providing our clients with market information flow, investment ideas and access to industry experts. We strive to provide value through unique industry knowledge. Our growing research practice is being built with domain experts who have a strong reputation amongst institutional investors. Auriga’s research analysts have also been recognized by numerous industry publications including, The Wall Street Journal and Bloomberg. Our bottom-up fundamental approach is data point driven with a primary focus on growth sectors within the technology and healthcare verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/11/2011 8:25 AM Buy
7.00 10.00
as of 12/30/2011
1 Week up  0.45 %
1 Month up  25.42 %
3 Months up  47.54 %
1 YTD down  -5.57 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/11/2010 8:25 AM Hold
5.62 5.00
6/21/2010 10:25 AM Hold
8.18 9.00
4/16/2010 8:25 AM Buy
23.75 36.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy